Lin Xu

2.6k total citations
84 papers, 1.8k citations indexed

About

Lin Xu is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Lin Xu has authored 84 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 27 papers in Infectious Diseases and 14 papers in Molecular Biology. Recurrent topics in Lin Xu's work include Tuberculosis Research and Epidemiology (25 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers) and Mycobacterium research and diagnosis (9 papers). Lin Xu is often cited by papers focused on Tuberculosis Research and Epidemiology (25 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers) and Mycobacterium research and diagnosis (9 papers). Lin Xu collaborates with scholars based in China, United States and Thailand. Lin Xu's co-authors include Bo Zhou, Hongzhi Sun, Huixia Li, Weiping Jia, Ronald C.W., Shufang Wu, Shufang Wu, Wei‐Jin Zang, Weijin Zang and Qinyue Guo and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lin Xu

77 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Xu China 26 605 448 379 293 273 84 1.8k
Antoni Castro Spain 25 497 0.8× 320 0.7× 128 0.3× 250 0.9× 285 1.0× 108 2.2k
William Alazawi United Kingdom 23 1.6k 2.6× 441 1.0× 160 0.4× 379 1.3× 415 1.5× 67 2.5k
Rika Kawakami Japan 27 458 0.8× 766 1.7× 381 1.0× 160 0.5× 287 1.1× 93 2.3k
Rosalinda Posadas‐Sánchez Mexico 22 380 0.6× 308 0.7× 123 0.3× 355 1.2× 300 1.1× 136 1.7k
Luigi Mario Castello Italy 23 336 0.6× 413 0.9× 285 0.8× 107 0.4× 305 1.1× 105 1.9k
Tomoya Nishino Japan 23 293 0.5× 430 1.0× 279 0.7× 54 0.2× 289 1.1× 184 2.1k
Gian Paolo Caviglia Italy 28 1.5k 2.5× 523 1.2× 144 0.4× 214 0.7× 426 1.6× 171 2.7k
Satoshi Suzuki Japan 27 269 0.4× 686 1.5× 236 0.6× 103 0.4× 262 1.0× 124 2.2k
Sabine Kurz Germany 21 586 1.0× 357 0.8× 192 0.5× 211 0.7× 230 0.8× 36 2.7k
Antonio Cannatà United Kingdom 26 206 0.3× 509 1.1× 418 1.1× 222 0.8× 367 1.3× 113 2.5k

Countries citing papers authored by Lin Xu

Since Specialization
Citations

This map shows the geographic impact of Lin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Xu more than expected).

Fields of papers citing papers by Lin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Xu. The network helps show where Lin Xu may publish in the future.

Co-authorship network of co-authors of Lin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Xu. A scholar is included among the top collaborators of Lin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Xu. Lin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Chen, Jinou, et al.. (2023). Trends and Projection of the Incidence of Active Pulmonary Tuberculosis in Southwestern China: Age-Period-Cohort Analysis. JMIR Public Health and Surveillance. 9. e48015–e48015. 11 indexed citations
4.
Chen, Jinou, et al.. (2022). Dose–response relationship between body mass index and tuberculosis in China: a population-based cohort study. BMJ Open. 12(3). e050928–e050928. 14 indexed citations
5.
Xu, Lin, et al.. (2021). NAMPT-mediated NAD+ biosynthesis suppresses activation of hepatic stellate cells and protects against CCl4-induced liver fibrosis in mice. Human & Experimental Toxicology. 40(12_suppl). S666–S675. 5 indexed citations
6.
Chen, Jinou, Zulma Vanessa Rueda, Liuping Chen, et al.. (2019). Role of community-based active case finding in screening tuberculosis in Yunnan province of China. Infectious Diseases of Poverty. 8(1). 92–92. 34 indexed citations
7.
Yang, Xinyu, Hongyu Ru, Hui Yang, et al.. (2018). [A study on genotype of 271 mycobacterium tuberculosis isolates in 6 prefectures in Yunnan Province].. PubMed. 52(1). 62–67. 1 indexed citations
8.
Chai, Sanbao, Lin Xu, Danyang Wang, et al.. (2018). The effect of diabetes self-management education on psychological status and blood glucose in newly diagnosed patients with diabetes type 2. Patient Education and Counseling. 101(8). 1427–1432. 52 indexed citations
9.
Abe, Eniola Michael, Xinxu Li, Robert Bergquist, et al.. (2018). Space-time clustering and associated risk factors of pulmonary tuberculosis in southwest China. Infectious Diseases of Poverty. 7(1). 91–91. 19 indexed citations
10.
Guo, Qinyue, Lin Xu, Huixia Li, et al.. (2017). 4-PBA reverses autophagic dysfunction and improves insulin sensitivity in adipose tissue of obese mice via Akt/mTOR signaling. Biochemical and Biophysical Research Communications. 484(3). 529–535. 28 indexed citations
11.
Xue, Jing, et al.. (2017). The clinical features of epithelioid hemangioendothelioma in a Han Chinese population. Medicine. 96(26). e7345–e7345. 13 indexed citations
13.
Khan, Mishal, et al.. (2017). Are global tuberculosis control targets overlooking an essential indicator? Prolonged delays to diagnosis despite high case detection rates in Yunnan, China. Health Policy and Planning. 32(suppl_2). ii15–ii21. 6 indexed citations
14.
Shen, Liping, et al.. (2016). Risk factors related to the failure of prevention of hepatitis B virus Mother-to-Child transmission in Yunnan, China. Vaccine. 35(4). 605–609. 13 indexed citations
15.
Zhou, Bo, Hao Li, Jingran Liu, et al.. (2016). Autophagic dysfunction is improved by intermittent administration of osteocalcin in obese mice. International Journal of Obesity. 40(5). 833–843. 22 indexed citations
16.
Liu, Fang & Lin Xu. (2015). Reliability and validity of Chinese version of Patient Dignity Inventory. ˜The œJournal of practical nursing. 31(1). 26–29. 1 indexed citations
17.
Levinger, Itamar, Lin Xu, Tara C. Brennan‐Speranza, et al.. (2015). The effects of muscle contraction and recombinant osteocalcin on insulin sensitivity ex vivo. Osteoporosis International. 27(2). 653–663. 39 indexed citations
18.
Wei, Xiaolin, et al.. (2015). An intervention of active TB case finding among smokers attending routine primary care facilities in China: an exploratory study. Transactions of the Royal Society of Tropical Medicine and Hygiene. 109(9). 545–552. 4 indexed citations
19.
Sun, Hongzhi, Lin Xu, Bo Zhou, Wei‐Jin Zang, & Shufang Wu. (2011). Depletion of insulin receptor substrate 2 reverses oncogenic transformation induced by v-src. Acta Pharmacologica Sinica. 32(5). 611–618. 3 indexed citations
20.
Chen, Yan, Lin Xu, Yong Liu, et al.. (2011). Research Advances at the Institute for Nutritional Sciences at Shanghai, China. Advances in Nutrition. 2(5). 428–439. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026